Type 2 myocardial infarction is associated with persistently elevated mortality rates compared with Type 1 myocardial infarction, disproportionately affecting African Americans.
Observational
Yes
Type 2 myocardial infarction is a heterogeneous clinical entity with persistently elevated mortality rates compared with type 1 myocardial infarction and a lack of standardized medical management.
p-value: p=<.001
Background: Type 2 myocardial infarction (T2MI) was first established as a unique entity in 2007. However, its clinical features are not well characterized. This study aimed to determine the clinical characteristics, predictors of mortality, and hospitalization trends of patients with T2MI. Methods: The National Inpatient Sample database was queried for patients hospitalized in the United States with T2MI (January 2018 to December 2019). Data were used to assess baseline characteristics, primary diagnoses, predictors of mortality, and hospitalization and mortality trends of T2MI. Results: < .001). Conclusions: T2MI is a unique and heterogeneous clinical entity. Despite increased awareness, there is a lack of standardization of medical management and timing for revascularization, even as mortality rates remain persistently elevated compared with T1MI. Certain demographics, including African Americans, may be disproportionately affected.
Rogers et al. (Wed,) conducted a observational in Type 2 myocardial infarction. Type 2 myocardial infarction vs. Type 1 myocardial infarction was evaluated on Mortality and hospitalization trends (p=<.001). Type 2 myocardial infarction is associated with persistently elevated mortality rates compared with Type 1 myocardial infarction, disproportionately affecting African Americans.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: